BioLargo (NASDAQ:BLGO) and FMC (NYSE:FMC) Critical Review

BioLargo (NASDAQ:BLGO) and FMC (NYSE:FMC) are both construction companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for BioLargo and FMC, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0	0	0	0	N/A
FMC	1	10	5	1	2.35

FMC has a consensus price target of $68.47, indicating a potential upside of 7.00%. Given FMC’s higher probable upside, analysts plainly believe FMC is more favorable than BioLargo.

Risk & Volatility

BioLargo has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, FMC has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Institutional and Insider Ownership

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 91.9% of FMC shares are owned by institutional investors. 20.3% of BioLargo shares are owned by company insiders. Comparatively, 0.9% of FMC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares BioLargo and FMC’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioLargo	-16.53%	-58.35%	-32.12%
FMC	33.97%	7.52%	2.67%

Valuation and Earnings

This table compares BioLargo and FMC”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23 million	5.91	-$3.50 million	($0.03)	-8.02
FMC	$4.49 billion	1.78	$1.32 billion	$8.96	7.14

FMC has higher revenue and earnings than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than FMC, indicating that it is currently the more affordable of the two stocks.

Summary

FMC beats BioLargo on 12 of the 14 factors compared between the two stocks.

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

About FMC

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.